MolNFT v1 · #47885 · protein
E292Q mutant of exo-B-(1,3)-glucanase from candida albicans in complex with two separately bound glucopyranoside units at 1.8 a
2PC8 · Hypothetical protein XOG1: “E292Q mutant of exo-B-(1,3)-glucanase from candida albicans in complex with two separately bound…”. X-ray diffraction, 1 ligand (BGC), 2 pockets (best druggability 0.64). MolNFT v1 #47885 on GenesisL1: 3D…
- PDB
- 2PC8
- Type
- protein
- Length
- 394 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Hypothetical protein XOG1
- EC
- 3.2.1.58
- UniProt
- Q5AIZ3
- Ligands
- BGC
- Pockets
- 2 · best druggability 0.64
Structure
x-ray diffraction · 1 distinct chain · 39% helix, 13% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Hypothetical protein XOG1 (EC 3.2.1.58) | protein | 394 | 39% helix, 13% strand | Q5AIZ3 |
Ligands and binding sites
- BGC · beta-D-glucopyranose · sugar · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 337 | 0.64 | 0.79 | 41 | BGC |
| 2 | 85 | 0.40 | 0.78 | 23 | empty |
Modifications
Observed in the structure: 2 disulfide (disulfide).
Compared structures
- 2PC8 · E292Q mutant of EXO-B-(1,3)-Glucanase from Candida Albicans in complex with two… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q5AIZ3
- Elsewhere: RCSB PDB 2PC8 · PDBe 2PC8 · UniProt Q5AIZ3
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.